Published in J Clin Endocrinol Metab on November 09, 2011
Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. Eur J Pediatr (2013) 0.98
Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity. Int J Obes (Lond) (2013) 0.95
1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes. PLoS One (2013) 0.94
Association between serum vitamin d and metabolic risk factors in korean schoolgirls. Osong Public Health Res Perspect (2013) 0.90
Vitamin D deficiency is associated with prediabetes in obese Swedish children. Acta Paediatr (2016) 0.90
A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. FASEB J (2012) 0.86
Slipped upper femoral epiphysis: Outcome after in situ fixation and capital realignment technique. Indian J Orthop (2013) 0.85
A randomized clinical trial of vitamin D supplementation in healthy adolescents. J Adolesc Health (2012) 0.84
Evidence-based and heuristic approaches for customization of care in cardiometabolic syndrome after spinal cord injury. J Spinal Cord Med (2012) 0.84
Association of serum 25-hydroxyvitamin D with insulin resistance and β-cell function in a healthy Chinese female population. Acta Pharmacol Sin (2013) 0.83
A meta-analysis of the relationship between vitamin D deficiency and obesity. Int J Clin Exp Med (2015) 0.82
Vitamin D levels and obstructive sleep apnoea in children. Sleep Med (2014) 0.82
Vitamin d deficiency and insufficiency in obese children and adolescents and its relationship with insulin resistance. Int J Endocrinol (2013) 0.81
Vitamin D insufficiency and insulin resistance in obese adolescents. Ther Adv Endocrinol Metab (2014) 0.81
Obesity and cancer: the role of vitamin D. BMC Cancer (2014) 0.79
High prevalence of vitamin D insufficiency/deficiency in Dutch multi-ethnic obese children. Eur J Pediatr (2015) 0.79
Adequate vitamin D status and adiposity contribute to bone health in peripubertal nonobese children. J Bone Miner Metab (2013) 0.79
Consumption of sweet foods and mammographic breast density: a cross-sectional study. BMC Public Health (2014) 0.78
Serum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents. PLoS One (2014) 0.78
25-OH-Vitamin D and procalcitonin levels after correction of acute hyperglycemia. Med Sci Monit (2013) 0.78
The ratio of parathyroid hormone to vitamin D is a determinant of cardiovascular risk and insulin sensitivity in adolescent girls. Metab Syndr Relat Disord (2012) 0.77
Increased risk for vitamin d deficiency in obese children with both celiac disease and type 1 diabetes. Gastroenterol Res Pract (2014) 0.76
Low Serum Vitamin D Levels Are Associated With Increased Arterial Stiffness in Youth With Type 2 Diabetes. Diabetes Care (2015) 0.76
Prevalence of hypovitaminosis D and associated factors in obese Spanish children. Nutr Diabetes (2017) 0.75
Association between intake of sugar-sweetened beverages and circulating 25-hydroxyvitamin D concentration among premenopausal women. Nutrients (2014) 0.75
Prevalence of hypovitaminosis D and its association with comorbidities of childhood obesity. Perm J (2014) 0.75
Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease. J Korean Med Sci (2015) 0.75
Risk assessment of obstructive sleep apnea syndrome in pediatric patients with vitamin D deficiency: A questionnaire-based study. Medicine (Baltimore) (2016) 0.75
Vitamin D Status, Insulin Resistance, Leptin-To-Adiponectin Ratio in Adolescents: Results of a 1-Year Lifestyle Intervention. Open Access Maced J Med Sci (2016) 0.75
A family-centered lifestyle intervention to improve body composition and bone mass in overweight and obese children 6 through 8 years: a randomized controlled trial study protocol. BMC Public Health (2013) 0.75
Vitamin D deficiency/insufficiency from childhood to adulthood: Insights from a sunny country. World J Clin Pediatr (2017) 0.75
Obese and overweight children and adolescents: an algorithmic clinical approach. Iran J Pediatr (2013) 0.75
Vitamin D Deficiency: A Potential Modifiable Risk Factor for Cardiovascular Disease in Children with Severe Obesity. Children (Basel) (2017) 0.75
High body mass index for age among US children and adolescents, 2003-2006. JAMA (2008) 16.00
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29
Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics (2002) 12.32
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics (1999) 11.20
Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics (1998) 10.51
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr (2004) 8.48
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr (2002) 7.34
Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics (2008) 6.99
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr (2003) 6.50
Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care (2004) 5.87
Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med (2004) 4.95
Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 3.62
Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab (2003) 3.22
Vitamin D deficiency inhibits pancreatic secretion of insulin. Science (1980) 3.00
Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics (2009) 2.99
Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care (2006) 2.84
Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism (2008) 2.73
Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J (2000) 2.57
Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics (2009) 2.46
Low circulating vitamin D in obesity. Calcif Tissue Int (1988) 2.23
The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res (2009) 1.86
1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology (1994) 1.83
Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics (2010) 1.76
Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab (2004) 1.66
Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol (2003) 1.60
Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab (2007) 1.58
Vitamin D status and its relation to age and body mass index. Horm Res (2006) 1.35
Screening for type 2 diabetes in obese youth. Pediatrics (2009) 1.17
Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines. J Biol Chem (1999) 1.08
Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. Int J Clin Pract (2006) 1.02
Congenital adrenal hyperplasia. N Engl J Med (2003) 4.05
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int (2010) 2.35
Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab (2007) 2.00
The very large G-protein-coupled receptor VLGR1: a component of the ankle link complex required for the normal development of auditory hair bundles. J Neurosci (2006) 1.93
Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS (2012) 1.90
Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab (2007) 1.66
Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol (2006) 1.66
Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet (2003) 1.58
Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol (2011) 1.57
Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem (2005) 1.57
Circadian variation in urine pH and uric acid nephrolithiasis risk. Nephrol Dial Transplant (2007) 1.51
Body fat content and distribution and urinary risk factors for nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.51
Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab (2012) 1.41
Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol (2013) 1.40
Stimulated growth hormone concentrations in obese pediatric patients with mild and severe insulin resistance: a pilot study. J Pediatr Endocrinol Metab (2010) 1.39
Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol (2013) 1.39
Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol Endocrinol (2010) 1.38
Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol (2008) 1.36
The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy. Mol Cell (2012) 1.29
Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol (2005) 1.26
Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab (2011) 1.24
Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics (2005) 1.22
Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system. J Biol Chem (2001) 1.22
The regulation of aldosterone synthase expression. Mol Cell Endocrinol (2004) 1.22
The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol (2003) 1.21
Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab (2005) 1.19
Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf (2007) 1.19
Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis (2006) 1.19
Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. J Biol Chem (2008) 1.18
Screening for type 2 diabetes in obese youth. Pediatrics (2009) 1.17
Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int (2013) 1.12
Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes. Pediatr Diabetes (2011) 1.11
Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women. J Clin Endocrinol Metab (2005) 1.05
Transient neonatal hypocalcemia: presentation and outcomes. Pediatrics (2012) 1.04
A role for the NGFI-B family in adrenal zonation and adrenocortical disease. Endocr Res (2004) 1.03
Loss of the transmembrane and cytoplasmic domains of the very large G-protein-coupled receptor-1 (VLGR1 or Mass1) causes audiogenic seizures in mice. Mol Cell Neurosci (2004) 1.03
Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J Clin Endocrinol Metab (2005) 1.03
Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes. Pediatr Res (2012) 0.96
Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus. Pediatr Diabetes (2005) 0.95
Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab (2013) 0.94
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.94
Significance of elevated parathyroid hormone after parathyroidectomy for primary hyperparathyroidism. Endocr Pract (2011) 0.91
Optimizing newborn screening for congenital adrenal hyperplasia. J Pediatr (2013) 0.91
SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation. Mol Endocrinol (2009) 0.91
Abnormalities of glucose homeostasis and the hypothalamic-pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Endocrinology (2007) 0.91
Developmental trajectories of metabolic control among White, Black, and Hispanic youth with type 1 diabetes. J Pediatr (2011) 0.91
Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation. Endocrinology (2007) 0.88
The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers. Kidney Int (2012) 0.88
Analysis of the very large G-protein coupled receptor gene (Vlgr1/Mass1/USH2C) in zebrafish. Gene (2005) 0.86
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. Int J Pediatr Endocrinol (2011) 0.86
Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate. J Urol (2009) 0.85
Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. J Clin Endocrinol Metab (2005) 0.84
Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis. Kidney Int (2008) 0.82
Studies on the very large G protein-coupled receptor: from initial discovery to determining its role in sensorineural deafness in higher animals. Adv Exp Med Biol (2010) 0.81
Time to failure of oral therapy in children with type 2 diabetes: a single center retrospective chart review. Pediatr Diabetes (2012) 0.81
High prevalence of gouty arthritis among the Hmong population in Minnesota. Arthritis Care Res (Hoboken) (2010) 0.80
HSD11B2 CA-repeat and sodium balance. Hypertens Res (2013) 0.80
Hyperinsulinemia and urinary calcium excretion in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab (2013) 0.80
A randomized controlled trial comparing motivational interviewing in education to structured diabetes education in teens with type 1 diabetes. Diabetes Care (2010) 0.80
Comparison of semi-empirical and computer derived methods for estimating urinary saturation of brushite. J Urol (2009) 0.80
Hypothyroidism in siblings due to a homozygous mutation of the TSH-beta subunit gene. J Pediatr Endocrinol Metab (2004) 0.79
Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting. Pediatr Diabetes (2004) 0.79
Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas. J Clin Endocrinol Metab (2005) 0.79
Autosomal recessive familial neurohypophyseal diabetes insipidus: onset in early infancy. Eur J Endocrinol (2009) 0.79
Somatic items in the assessment of depressive symptoms in pediatric patients with diabetes. J Behav Med (2010) 0.79
Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2. J Hypertens (2005) 0.78
Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas. J Clin Endocrinol Metab (2003) 0.78
Contribution of hexose-6-phosphate dehydrogenase to NADPH content and redox environment in the endoplasmic reticulum. Redox Rep (2010) 0.78
Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma. Endocr Pract (2009) 0.78
Ectopic atypical parathyroid lipoadenoma: a rare cause of severe primary hyperparathyroidism. J Bone Miner Metab (2012) 0.78
Fasting versus 24-h urine pH in the evaluation of nephrolithiasis. Urol Res (2011) 0.77
P53 and cellular glucose uptake. Endocr Res (2012) 0.77
Institution of basal-bolus therapy at diagnosis for children with type 1 diabetes mellitus. Pediatrics (2009) 0.77
Safety of bisphosphonates. Rheum Dis Clin North Am (2012) 0.77
Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Curr Opin HIV AIDS (2016) 0.77
Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease. AIDS (2016) 0.76
Maternal depressive symptoms predict adolescent healthcare utilization and charges in youth with type 1 diabetes (T1D). Health Psychol (2013) 0.76
Adrenarche. Rev Endocr Metab Disord (2009) 0.76
Prostacyclin regulates bone growth via the Epac/Rap1 pathway. Endocrinology (2014) 0.76
Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β-Cells. ACS Chem Biol (2016) 0.75
The Relation of Questionnaire and Performance-Based Measures of Executive Functioning With Type 1 Diabetes Outcomes Among Late Adolescents. Health Psychol (2016) 0.75
The impact of obesity on the presentation of primary hyperparathyroidism. J Clin Endocrinol Metab (2014) 0.75
Dietary calcium, obesity and hypertension--the end of the road? J Clin Endocrinol Metab (2005) 0.75
Longer HSD11B2 CA-repeat in impaired glucose tolerance and type 2 diabetes. Endocr J (2013) 0.75
Acute interstitial nephritis complicating a new diagnosis of Wegener's granulomatosis. Hawaii Med J (2008) 0.75
Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study. J Investig Med (2015) 0.75
Role of local 11beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) expression in determining the phenotype of adrenal adenomas. Endocr Res (2002) 0.75